Cargando…
On the momentum toward vaccine self-sufficiency in the BRICS: an integrative review of the role of pharmaceutical entrepreneurship and innovation
BACKGROUND: With the perspicuous effect of COVID-19 on vaccine demand, academic and business interest in vaccine production in the BRICS nations (Brazil, the Russian Federation, India, China, and South Africa) has reached a crescendo. Aware of a “dark” past when the BRICS depended heavily on vaccine...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10591189/ https://www.ncbi.nlm.nih.gov/pubmed/37876712 http://dx.doi.org/10.3389/fpubh.2023.1116092 |
_version_ | 1785124172410650624 |
---|---|
author | Zhang, Yongqiang Li, Hongbo Xu, Xinglong Antwi, Henry Asante |
author_facet | Zhang, Yongqiang Li, Hongbo Xu, Xinglong Antwi, Henry Asante |
author_sort | Zhang, Yongqiang |
collection | PubMed |
description | BACKGROUND: With the perspicuous effect of COVID-19 on vaccine demand, academic and business interest in vaccine production in the BRICS nations (Brazil, the Russian Federation, India, China, and South Africa) has reached a crescendo. Aware of a “dark” past when the BRICS depended heavily on vaccines and pharmaceuticals from other parts of the world, academic curiosity on how the BRICS countries have leveraged vaccine self-sufficiency and become the hub of global vaccine production and supply is justifiable, especially in times of ineffable pandemics. METHODS: The articles were searched from November 2020 to December 2022. Within this period, an electronic search of 13 reputable healthcare and public databases was conducted. The initial searches from the designated databases yielded a total of 3,928 articles. Then, duplicated studies were removed through a two-step process, articles without titles and abstracts were excluded, and the remaining 898 articles that met the qualification assessment criteria were evaluated for article quality. RESULTS: The main entrepreneurial innovations that have quickened the pace of vaccine self-sufficiency in the BRICS include investment in artificial intelligence (AI), Big Data Analytics, and Blockchain technologies. These help to speed up the drug delivery process by enhancing patient identification or optimizing potential drug candidates for clinical trials and production. CONCLUSION: Over the past 20 years, the BRICS nations have achieved major strides in vaccine development, regulation, and production. The creation of the BRICS Vaccine Research and Development (R&D) Center will have a significant impact on vaccine cost and accessibility given the anticipated development of stronger research capability, production, and distribution technology, as well as stronger standardization to improve vaccine production quality in the near future. It is anticipated that the BRICS’ contributions to vaccine development will alter the global vaccination market and hasten the availability of vaccinations in developing nations. The challenge is turning these hopes into concrete plans of action and outcomes. |
format | Online Article Text |
id | pubmed-10591189 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-105911892023-10-24 On the momentum toward vaccine self-sufficiency in the BRICS: an integrative review of the role of pharmaceutical entrepreneurship and innovation Zhang, Yongqiang Li, Hongbo Xu, Xinglong Antwi, Henry Asante Front Public Health Public Health BACKGROUND: With the perspicuous effect of COVID-19 on vaccine demand, academic and business interest in vaccine production in the BRICS nations (Brazil, the Russian Federation, India, China, and South Africa) has reached a crescendo. Aware of a “dark” past when the BRICS depended heavily on vaccines and pharmaceuticals from other parts of the world, academic curiosity on how the BRICS countries have leveraged vaccine self-sufficiency and become the hub of global vaccine production and supply is justifiable, especially in times of ineffable pandemics. METHODS: The articles were searched from November 2020 to December 2022. Within this period, an electronic search of 13 reputable healthcare and public databases was conducted. The initial searches from the designated databases yielded a total of 3,928 articles. Then, duplicated studies were removed through a two-step process, articles without titles and abstracts were excluded, and the remaining 898 articles that met the qualification assessment criteria were evaluated for article quality. RESULTS: The main entrepreneurial innovations that have quickened the pace of vaccine self-sufficiency in the BRICS include investment in artificial intelligence (AI), Big Data Analytics, and Blockchain technologies. These help to speed up the drug delivery process by enhancing patient identification or optimizing potential drug candidates for clinical trials and production. CONCLUSION: Over the past 20 years, the BRICS nations have achieved major strides in vaccine development, regulation, and production. The creation of the BRICS Vaccine Research and Development (R&D) Center will have a significant impact on vaccine cost and accessibility given the anticipated development of stronger research capability, production, and distribution technology, as well as stronger standardization to improve vaccine production quality in the near future. It is anticipated that the BRICS’ contributions to vaccine development will alter the global vaccination market and hasten the availability of vaccinations in developing nations. The challenge is turning these hopes into concrete plans of action and outcomes. Frontiers Media S.A. 2023-10-09 /pmc/articles/PMC10591189/ /pubmed/37876712 http://dx.doi.org/10.3389/fpubh.2023.1116092 Text en Copyright © 2023 Zhang, Li, Xu and Antwi. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Public Health Zhang, Yongqiang Li, Hongbo Xu, Xinglong Antwi, Henry Asante On the momentum toward vaccine self-sufficiency in the BRICS: an integrative review of the role of pharmaceutical entrepreneurship and innovation |
title | On the momentum toward vaccine self-sufficiency in the BRICS: an integrative review of the role of pharmaceutical entrepreneurship and innovation |
title_full | On the momentum toward vaccine self-sufficiency in the BRICS: an integrative review of the role of pharmaceutical entrepreneurship and innovation |
title_fullStr | On the momentum toward vaccine self-sufficiency in the BRICS: an integrative review of the role of pharmaceutical entrepreneurship and innovation |
title_full_unstemmed | On the momentum toward vaccine self-sufficiency in the BRICS: an integrative review of the role of pharmaceutical entrepreneurship and innovation |
title_short | On the momentum toward vaccine self-sufficiency in the BRICS: an integrative review of the role of pharmaceutical entrepreneurship and innovation |
title_sort | on the momentum toward vaccine self-sufficiency in the brics: an integrative review of the role of pharmaceutical entrepreneurship and innovation |
topic | Public Health |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10591189/ https://www.ncbi.nlm.nih.gov/pubmed/37876712 http://dx.doi.org/10.3389/fpubh.2023.1116092 |
work_keys_str_mv | AT zhangyongqiang onthemomentumtowardvaccineselfsufficiencyinthebricsanintegrativereviewoftheroleofpharmaceuticalentrepreneurshipandinnovation AT lihongbo onthemomentumtowardvaccineselfsufficiencyinthebricsanintegrativereviewoftheroleofpharmaceuticalentrepreneurshipandinnovation AT xuxinglong onthemomentumtowardvaccineselfsufficiencyinthebricsanintegrativereviewoftheroleofpharmaceuticalentrepreneurshipandinnovation AT antwihenryasante onthemomentumtowardvaccineselfsufficiencyinthebricsanintegrativereviewoftheroleofpharmaceuticalentrepreneurshipandinnovation |